Cargando…
Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment
Ischemia/reperfusion injury (IRI) remains a major problem in organ transplantation, which represents the main cause of graft dysfunction posttransplantation. Hepatic IRI is characterized by an excessive inflammatory response within the liver. Mesenchymal stem cells (MSCs) have been shown to be immun...
Autores principales: | Li, Shihui, Zheng, Xu, Li, Hui, Zheng, Jun, Chen, Xiaolong, Liu, Wei, Tai, Yan, Zhang, Yingcai, Wang, Genshu, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304871/ https://www.ncbi.nlm.nih.gov/pubmed/30622980 http://dx.doi.org/10.1155/2018/7283703 |
Ejemplares similares
-
SOD2 overexpression in bone marrow-derived mesenchymal stem cells ameliorates hepatic ischemia/reperfusion injury
por: Li, Qiuyun, et al.
Publicado: (2021) -
Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury
por: Liu, Yung-Yang, et al.
Publicado: (2017) -
Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat Model
por: Kanazawa, Hiroyuki, et al.
Publicado: (2011) -
β-Arrestin-2 attenuates hepatic ischemia-reperfusion injury by activating PI3K/Akt signaling
por: Chen, Xiaolong, et al.
Publicado: (2020) -
MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mitophagy in liver ischemia/reperfusion injury through AMPKα activation
por: Zheng, Jun, et al.
Publicado: (2020)